Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts

Normodense human peripheral blood eosinophils were isolated under sterile conditions from the 22/23 and 23/24% interfaces and the cell pellet of metrizamide gradients. After culture for 7 d in RPMI media in the presence of 50 pM biosynthetic (recombinant) human granulocyte/macrophage colony-stimulating factor (rH GM-CSF), 43 +/- 7% (mean +/- SEM, n = 8) of the cells were viable; in the absence of rH GM- CSF, no eosinophils survived. The rH GM-CSF-mediated viability was concentration dependent; increased survival began at a concentration of 1 pM, a 50% maximal response was attained at approximately 3 pM, and a maximal effect was reached at concentrations of greater than or equal to 10 pM rH GM-CSF. In the presence of rH GM-CSF and mouse 3T3 fibroblasts, 67 +/- 6% (mean +/- SEM, n = 8) of the eosinophils survived for 7 d. In a comparative analysis, there was no difference in eosinophil viability after 7 and 14 d (n = 3) in the presence of 50 pM GM-CSF and fibroblasts. Culture with fibroblasts alone did not support eosinophil survival. The addition of fibroblast-conditioned media to rH GM-CSF did not further improve eosinophil viability, indicating a primary role for GM-CSF in supporting these eosinophil cell suspensions ex vivo and a supplementary role for 3T3 fibroblasts. Eosinophils cultured for 7 d localized on density gradient sedimentation at the medium/18, 18/20, and 20/21 interfaces of metrizamide gradients, indicating a change to the hypodense phenotype from their original normodense condition. In addition, the cultured eosinophils generated approximately 2.5-fold more LTC4 than freshly isolated cells when stimulated with the calcium ionophore A23187 and manifested sevenfold greater antibody-dependent killing of S. mansoni larvae than the freshly isolated, normodense cells from the same donor. Thus we demonstrate the rH GM-CSF dependent conversion in vitro of normodense human eosinophils to hypodense cells possessing the augmented biochemical and biological properties characteristic of the hypodense eosinophils associated with a variety of hypereosinophilic syndromes. In addition, these studies provide a culture model of at least 14 d suitable for the further characterization of hypodense eosinophils.

[1]  A. Sheffer,et al.  Synthesis and release of leukotriene C4 by human eosinophils. , 1987, Journal of immunology.

[2]  J. Dipersio,et al.  Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor. , 1986, Journal of immunology.

[3]  J. Gamble,et al.  Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. , 1986, The Journal of clinical investigation.

[4]  K. Austen,et al.  Coculture of interleukin 3-dependent mouse mast cells with fibroblasts results in a phenotypic change of the mast cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[5]  C. Begley,et al.  Purified colony-stimulating factors enhance the survival of human neutrophils and eosinophils in vitro: a rapid and sensitive microassay for colony-stimulating factors. , 1986, Blood.

[6]  M. Tomonaga,et al.  High-affinity binding of granulocyte-macrophage colony-stimulating factor to normal and leukemic human myeloid cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[7]  K. Austen,et al.  Fibroblasts maintain the phenotype and viability of the rat heparin-containing mast cell in vitro. , 1985, Journal of immunology.

[8]  G. Nossal,et al.  A high-efficiency cloning system for single hapten-specific B lymphocytes that is suitable for assay of putative growth and differentiation factors. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[9]  D. Golde,et al.  Purified human granulocyte-macrophage colony-stimulating factor: direct action on neutrophils. , 1984, Science.

[10]  M. Vadas,et al.  Maturation In Vivo of Schistosoma mansoni Schistosomula After Culture In Vitro with Granulocytes and Antibody , 1983, Infection and immunity.

[11]  M. Vadas,et al.  A new method for the purification of human eosinophils and neutrophils, and a comparison of the ability of these cells to damage schistosomula of Schistosoma mansoni. , 1979, Journal of immunology.

[12]  J. Gold,et al.  Schistosomiasis in the congenitally athymic (nude) mouse. I. Thymic dependency of eosinophilia, granuloma formation, and host morbidity. , 1977, Journal of immunology.

[13]  E D Robin,et al.  Total eosinophil counts in the management of bronchial asthma. , 1975, The New England journal of medicine.

[14]  A. Basten,et al.  Mechanisms for Eosinophilic and Neutrophilic Leucocytoses , 1971, British medical journal.

[15]  C. Spry MECHANISM OF EOSINOPHILIA , 1971 .

[16]  P. Beeson,et al.  Mechanism of eosinophilia. II. Role of the lymphocyte. , 1970 .

[17]  N. Maldonado,et al.  Hyperinfection syndrome with Strongyloides stercoralis. , 1970, Annals of internal medicine.

[18]  M. Samter,et al.  Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. , 1968, Annals of internal medicine.

[19]  Clark,et al.  Biologic properties in vitro of a recombinant human granulocyte-macrophage colony-stimulating factor. , 1986, Blood.

[20]  P. Sehgal,et al.  Stimulation of haematopoiesis in primates by continuous infusion of recombinant human GM-CSF , 1986, Nature.

[21]  H. Mita,et al.  Release of leukotriene C4 from human eosinophils and its relation to the cell density. , 1985, International archives of allergy and applied immunology.

[22]  A. Butterworth Cell-mediated damage to helminths. , 1984, Advances in parasitology.

[23]  A. Capron,et al.  Heterogeneity of human peripheral blood eosinophils: variability in cell density and cytotoxic ability in relation to the level and the origin of hypereosinophilia. , 1983, International archives of allergy and applied immunology.

[24]  E. Pick,et al.  Lymphokine-related eosinophil responses. , 1980 .

[25]  A. Mahmoud,et al.  Eosinophilopoietin production: relationship to eosinophilia of infection and thymus function. , 1979, Transactions of the Association of American Physicians.

[26]  X. García Gama [Intolerance to aspirin]. , 1976, Alergia.

[27]  M. Conrad Hematologic manifestations of parasitic infections. , 1971, Seminars in hematology.